Shire plc (ADR) (NASDAQ:SHPG)

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Costco, GW Pharma, NXP, Southwest Air, Teva, Ulta, Wells Fargo and More

Stocks were indicated marginally lower after a strong jobs numbers on Friday morning, but despite a sell-off, the market remains close to all-time highs. Investors have seen less upside when ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, AT&T, BBVA, Cisco, Dollar Tree, Facebook, Roku, Seagate, Turkcell, Verizon and More

Stocks were indicated lower on Tuesday after the three-day weekend, but the major market equity indexes may have recently hit all-time highs after a strong earnings season. Investors have seen ...
Read Full Story »

What a Buyout Could Mean for Shire

Shares of Shire PLC (NASDAQ: SHPG) saw a solid gain on Wednesday after the firm announced that it received an offer to be acquired by Takeda Pharmaceutical. Takeda said in ...
Read Full Story »

10 Top Irish Stocks Worth Keeping an Eye On

If the St. Patrick’s Day observances have investors pondering opportunities in the Emerald Isle, there are a few things to know. First, Ireland has been known for some time for ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Home Depot, PagSeguro, Snap, Walmart, Wingstop and More

Stocks have reminded us that the market can go back down and have volatility again, but there is also the six-year-old trend of buying the dips as the top rewarding ...
Read Full Story »

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Despite a roaring market in 2017, in which the S&P 500 was up almost 20% on the year, the specialty pharmaceutical group and biotechs severely underperformed. In addition, the performance ...
Read Full Story »

What Shire Is Planning With Its Newest FDA Submission

Although Shire PLC (NASDAQ: SHPG) is not seeing much of a bump in its share price, the firm is creating a lot of value with its most recent submission to ...
Read Full Story »

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

With a market that has become as expensive as this one, there is one key driver that can keep things going, and that’s positive earnings or guidance for the next ...
Read Full Story »

10 Credit Suisse Top European Stock Picks for US Investors

The U.S. stock market is currently sitting at all-time highs, and investors have to keep in mind that this bull market is now nearly nine years old. For about five ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Chesapeake Energy, DowDuPont, Equifax, Gap, Nike, Tesla, Under Armour and More

Stocks were indicated to open marginally higher on Tuesday, but investors need to keep in mind that the major equity indexes are at or just under all-time highs. Investors keep ...
Read Full Story »

Leon Cooperman Sees Mixed Market Ahead but Loves 5 Top Stock Picks

Leon Cooperman of Omega Advisors spoke at the Delivering Alpha conference on Tuesday morning. He is a heavyweight on Wall Street and is considered one of the preeminent hedge fund ...
Read Full Story »

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Healthcare, which struggled mightily during the brutal election season last year and even back into 2015, has had a nice first half of 2017. Given the current nosebleed levels of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Costco, Deckers Outdoor, Qualcomm, Shell, Shire, Ulta Beauty and More

The market continued its winning ways yesterday, and while we're off to a slow start this morning, it’s looking like the month of May should end up closing out with gains ...
Read Full Story »

Merrill Lynch Raises Price Targets on 5 Stocks With Blow-Out Earnings

The higher the market goes, the harder it is to justify many of the multiples being applied to shares. The big moves in the market since the election last November ...
Read Full Story »
Medicine pills

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Ever since the Hillary Clinton high drug price tweet in September of last year, the major pharmaceuticals and biotechs have struggled, and while performance has improved over the past quarter, ...
Read Full Story »